Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Block with Bupivacaine After Cesarean Section
NCT01986049Phase 3Withdrawn
- Sponsor
- NewYork-Presbyterian Brooklyn Methodist Hospital
- Start
- Feb 2013
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupivacaine in postoperative pain, sponsored by NewYork-Presbyterian Brooklyn Methodist Hospital. Planned start Feb 2013; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01986049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01986049.